In vivo T-cell depletion with antithymocyte globulin or alemtuzumab for unrelated donor stem cell transplantation with reduced intensity conditioning: results of a multicentre randomized phase II clinical trial (the Global study) from the GITMO

被引：0
|
作者：
Algarotti, A. [1 ]
Mico, C. [1 ]
Corradini, P. [2 ]
Falda, M. [3 ]
Alessandrino, E. P. [4 ]
Fanin, R. [5 ]
Tagliaferri, E. [6 ]
Castagna, L. [7 ]
Mordini, N. [8 ]
Sica, S. [9 ]
Santarone, S. [10 ]
Levis, A. [11 ]
Iori, A. [12 ]
Pollichieni, S. [13 ]
Sacchi, N. [13 ]
Scarano, M. [14 ]
Masciulli, A. [14 ]
Marchioli, R. [14 ]
Bacigalupo, A. [15 ]
Bosi, A. [16 ]
Rambaldi, A. [1 ]
机构：
[1] Osped Papa Giovanni XXIII, Bergamo, Italy
[2] Ist Nazl Tumori, I-20133 Milan, Italy
[3] Osped San Giovanni Battista Torino, Turin, Italy
[4] Policlin San Matteo, I-27100 Pavia, Italy
[5] AO Univ Udine, Udine, Italy
[6] Osped Maggiore Policlin, Milan, Italy
[7] Ist Clin Humanitas, Milan, Italy
[8] AO Santa Croce & Carle, Cuneo, Italy
[9] Policlin Gemelli, Rome, Italy
[10] Osped Civile, Pescara, Italy
[11] AO SS Antonio & Biagio & C Arrigo, Alessandria, Italy
[12] Univ Roma La Sapienza, Rome, Italy
[13] Osped Galliera, Genoa, Italy
[14] Ist Mario Negri Sud, Santa Maria Imbaro, Italy
[15] Osped San Martino Genova, Genoa, Italy
[16] Osped Careggi, Florence, Italy
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S60 / S61
页数：2
相关论文
共 50 条
  • [41] Impact of HLA class I and class II DNA high-resolution HLA typing on clinical outcome in adult unrelated stem cell transplantation after in vivo T-cell depletion with alemtuzumab
    Perz, Jolanta B.
    Szydo, Richard
    Sergeant, Ruhena
    Sanz, Jaime
    O'Shea, Derville
    Khan, Thahmina
    Davey, Nick
    Loaiza, Sandra
    Davis, John
    Apperley, Jane F.
    Olavarria, Eduardo
    TRANSPLANT IMMUNOLOGY, 2007, 18 (02) : 179 - 185
  • [42] Excellent results after reduced intensity conditioning and T-cell replete allogeneic blood stem cell transplantation in haemophagocytic lymphohistiosis
    Mathias, Felber
    Mathias, Hauri-Hohl
    Karim, Kentouche
    Anders, Fasth
    Jana, Pachlopnik-Schmid
    Moustapha, Hassan
    Colin, Steward
    Kurt, Leibundgut
    Kerstin, Hagemann
    Tayfun, Gungor
    SWISS MEDICAL WEEKLY, 2016, 146 : 6S - 6S
  • [43] T-cell depletion does not necessarily compromise donor stem cell engraftment in patients receiving reduced-intensity conditioning regimens - Reply
    Passweg, J
    Gratwohl, A
    BONE MARROW TRANSPLANTATION, 2003, 31 (12) : 1179 - 1179
  • [44] Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results
    Koreth, John
    Kim, Haesook T.
    Lange, Paulina B.
    Poryanda, Samuel J.
    Reynolds, Carol G.
    Rai, Sharmila Chamling
    Armand, Philippe
    Cutler, Corey S.
    Ho, Vincent T.
    Glotzbecker, Brett
    Yusuf, Rushdia
    Nikiforow, Sarah
    Chen, Yi-Bin
    Dey, Bimalangshu
    McMasters, Malgorzata
    Ritz, Jerome
    Blazar, Bruce R.
    Soiffer, Robert J.
    Antin, Joseph H.
    Alyea, Edwin P., III
    HAEMATOLOGICA, 2018, 103 (03) : 522 - 530
  • [45] Predictive factors and impact of full donor T-cell chimerism after reduced-intensity conditioning allogeneic stem cell transplantation
    Mohty, M
    Avinens, O
    Faucher, C
    Furst, S
    de Lavallade, H
    El-Cheikh, J
    Viens, P
    Gastaut, JA
    Blaise, D
    Eliaou, JF
    BONE MARROW TRANSPLANTATION, 2006, 37 : S200 - S200
  • [46] Prospective Phase II Study of Pre-Administration of Rabbit Antithymocyte Globulin (rATG, Thymoglobulin ®) to Maximize Early T-Cell Chimerism Following Allogeneic Reduced Intensity Conditioning Transplant (RICT) through Differential in-Vivo Depletion of Recipient Versus Donor T-Cells
    Sanacore, Melissa
    Brown, Stacey
    Roth, Candice G.
    Zhang, Ming
    Smith, Pauline
    Holland, H. Kent
    Morris, Lawrence E.
    Solomon, Scott R.
    Bashey, Asad
    BLOOD, 2009, 114 (22) : 1308 - 1309
  • [47] In vivo T cell depletion with low-dose rabbit antithymocyte globulin results in low transplant-related mortality and low relapse incidence following unrelated hematopoietic stem cell transplantation
    Nachbaur, D
    Eibl, B
    Kropshofer, G
    Meister, B
    Mitterschiffthaler, A
    Schennach, H
    Fischer, G
    Kopp, M
    Gunsilius, E
    Gastl, G
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2002, 11 (04): : 731 - 737
  • [48] Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma
    Kröger, N
    Shaw, B
    Iacobelli, S
    Zabelina, T
    Peggs, K
    Shimoni, A
    Nagler, A
    Binder, T
    Eiermann, T
    Madrigal, A
    Schwerdtfeger, R
    Kiehl, M
    Sayer, HG
    Beyer, J
    Bornhäuser, M
    Ayuk, F
    Zander, AR
    Marks, DI
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (05) : 631 - 643
  • [49] Radiation-free reduced-intensity hematopoietic stem cell transplantation with in vivo T-cell depletion from matched related and unrelated donors for Fanconi anemia: prognostic factor analysis
    Rostami, Tahereh
    Mousavi, Seyed Ali
    Kiumarsi, Azadeh
    Kasaeian, Amir
    Rad, Soroush
    Yaghmaie, Marjan
    Ghavamzadeh, Ardeshir
    Mousavi, Seied Asadollah
    EXPERIMENTAL HEMATOLOGY, 2022, 109 : 27 - 34
  • [50] Preconditioning Absolute Lymphocyte Count and Transplantation Outcomes in Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation Recipients with Reduced-Intensity Conditioning and Antithymocyte Globulin Treatment
    Woo, Go-Un
    Hong, Junshik
    Kim, Hyangseon
    Byun, Ja Min
    Koh, Youngil
    Shin, Dong-Yeop
    Kim, Inho
    Yoon, Sung-Soo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (10) : 1855 - 1860
12345